Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility

Treatment options for influenza B virus infections are limited to neuraminidase inhibitors (NAIs), which block the neuraminidase (NA) glycoprotein on the virion surface. The development of NAI resistance would therefore result in a loss of antiviral treatment options for influenza B virus infections...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Main Authors: Farrukee, R., Zarebski, A. E., McCaw, J. M., Bloom, J. D., Reading, P. C., Hurt, A. C.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2018
Assuntos:
Antiviral Agents
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201084/
https://ncbi.nlm.nih.gov/pubmed/30201817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01081-18
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares